This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
Centene (CNC) in Focus: Stock Moves 9.2% Higher
by Zacks Equity Research
Centene (CNC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Midterm Elections Put These Health Insurers in Focus
by Sapna Bagaria
U.S. Health Insurers should gain from Medicaid Expansion that might be bought by Democratic control in the House of Representatives.
US Stocks Enjoy Highest Post-Midterm Gains Since 1982: 5 Picks
by Swarup Gupta
A large swathe of market watchers thinks that a gridlocked Congress will be beneficial for U.S. equity markets.
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter
5 Top Stocks to Make the Most of a Divided Congress
by Tirthankar Chakraborty
Gridlock in Washington bodes well for healthcare and defense stocks, which calls for investing in such a space for the time being.
Election Day 2018: Here Are the Winners & Losers
by Tirthankar Chakraborty
One of the most awaited midterm elections in American history is upon us. Let's thus look at the sectors most likely to be impacted by the election results.
Zacks.com highlights: Illumina, Molina Healthcare, Twitter, Vocera Communications and WNS Holdings
by Zacks Equity Research
Zacks.com highlights: Illumina, Molina Healthcare, Twitter, Vocera Communications and WNS Holdings
Hasbro, Best Buy, Hess, Molina Health and Tetra Tech highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Hasbro, Best Buy, Hess, Molina Health and Tetra Tech highlighted as Zacks Bull and Bear of the Day
Go Beyond Earnings Growth, Bet on Beat With 5 Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
A Horror of a Month: Zacks November Market Strategy
by John Blank
On Nov.1st, the S&P 500 traded at 2711. Thirty days earlier, the S&P 500 traded at 2920. We lost 209 points, and went -7.1% lower.
Molina Healthcare's (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 earnings beat on the back of an effective performance management and a margin recovery plan.
Molina (MOH) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 64.85% and -0.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Q3 Earnings to Watch on Oct 31: ANTM, MOH, ESRX
by Zacks Equity Research
Healthcare stocks should gain from increase in revenues, higher premiums and enrollment partly offset by increase in expenses.
Zacks.com highlights: Tilly's, Crocs, Cadence Design Systems and Molina Healthcare
by Zacks Equity Research
Zacks.com highlights: Tilly's, Crocs, Cadence Design Systems and Molina Healthcare
What's in the Offing for Aetna (AET) This Earnings Season?
by Zacks Equity Research
Aetna's (AET) third-quarter earnings to gain from higher revenues, partly offset by increase in expenses.
Can Healthy Top-Line Growth Aid Ribbon's (RBBN) Q3 Earnings?
by Zacks Equity Research
Ribbon (RBBN) is likely to report higher year-over-year revenues in the third quarter of 2018 owing to healthy organic and inorganic growth initiatives.
Molina Healthcare's (MOH) Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Molina Healthcare (MOH) is likely to perform well in the third quarter on the back of a solid Medicaid business and its operational excellence.
4 Impressive Liquid Stocks for Maximum Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that can help investors build a winning portfolio.
Will Expenses Hurt WellCare Health's (WCG) Q3 Earnings?
by Zacks Equity Research
WellCare Health's (WCG) Q3 bottom line might suffer due to escalating expenses.
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKJ
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
Universal Health Services (UHS) Q3 Earnings: A Beat in the Cards?
by Zacks Equity Research
United Health's (UHS) third quarter is likely to gain from solid segmental performances and higher number of admissions.
Molina (MOH) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Obamacare Set to Gain From Mid-Term Polls: 4 HMO Picks
by Swarup Gupta
HMOs, which have expanded their market share in the post-Obamacare era, are expected to gain from this trend.